메뉴 건너뛰기




Volumn 77, Issue 6, 1996, Pages 1101-1106

Quantitative analysis of vascular endothelial growth factor in primary breast cancer

Author keywords

basic FGF; breast cancer; HGF; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN;

EID: 0029985805     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960315)77:6<1101::AID-CNCR15>3.0.CO;2-5     Document Type: Article
Times cited : (197)

References (28)
  • 1
    • 0027043136 scopus 로고
    • Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
    • Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
    • (1992) J Natl Cancer Inst , vol.84 , pp. 1875-1887
    • Weidner, N.1    Folkman, J.2    Pozza, F.3    Bevilacqua, P.4    Allred, E.N.5    Moore, D.H.6
  • 2
    • 0026497186 scopus 로고
    • Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
    • Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
    • (1992) Lancet , vol.340 , pp. 1120-1124
    • Horak, E.R.1    Leek, R.2    Klenk, N.3    Lejeune, S.4    Smith, K.5    Stuart, N.6
  • 3
    • 0027373841 scopus 로고
    • Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
    • Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-4.
    • (1993) Int J Cancer , vol.55 , pp. 371-374
    • Toi, M.1    Kashitani, J.2    Tominaga, T.3
  • 4
    • 0028227085 scopus 로고
    • Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic invasion are relevant prognostic markers in node-negative breast carcinoma
    • Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994;12:454-66.
    • (1994) J Clin Oncol , vol.12 , pp. 454-466
    • Gasparini, G.1    Weidner, N.2    Bevilacqua, P.3    Maluta, S.4    Palma, P.D.5    Caffo, O.6
  • 5
    • 0028939826 scopus 로고
    • Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
    • Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-82.
    • (1995) J Clin Oncol , vol.13 , pp. 765-782
    • Gasparini, G.1    Harris, A.L.2
  • 6
    • 0024384470 scopus 로고
    • Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
    • Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8.
    • (1989) Biochem Biophys Res Commun , vol.161 , pp. 851-858
    • Ferrara, N.1    Henzel, W.J.2
  • 7
    • 0021111648 scopus 로고
    • Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
    • Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.
    • (1983) Science , vol.219 , pp. 983-985
    • Senger, D.R.1    Galli, S.J.2    Dvorak, A.M.3    Perruzzi, C.A.4    Harvey, V.S.5    Dvorak, H.F.6
  • 8
    • 0000491207 scopus 로고
    • Primary structure of bovine basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF
    • Esch F, Baird A, Ling N, Ueno N, Hill F, Deneroy L, et al. Primary structure of bovine basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 1985;82:6507-11.
    • (1985) Proc Natl Acad Sci USA , vol.82 , pp. 6507-6511
    • Esch, F.1    Baird, A.2    Ling, N.3    Ueno, N.4    Hill, F.5    Deneroy, L.6
  • 9
    • 0021285134 scopus 로고
    • Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats
    • Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochem Biophys Res Commun 1984;122: 1450-9.
    • (1984) Biochem Biophys Res Commun , vol.122 , pp. 1450-1459
    • Nakamura, T.1    Nawa, K.2    Ichihara, A.3
  • 10
    • 0028115003 scopus 로고
    • Association of vascular endothelial growth factor expression with tumor angiogenesis and early response in primary breast cancer
    • Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and early response in primary breast cancer. Jpn J Cancer Res 1994;85:1045-9.
    • (1994) Jpn J Cancer Res , vol.85 , pp. 1045-1049
    • Toi, M.1    Hoshina, S.2    Takayanagi, T.3    Tominaga, T.4
  • 11
    • 0029143990 scopus 로고
    • Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
    • Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Br J Cancer Res Treat 1995;36:193-204.
    • (1995) Br J Cancer Res Treat , vol.36 , pp. 193-204
    • Toi, M.1    Inada, K.2    Suzuki, H.3    Tominaga, T.4
  • 13
    • 0028353491 scopus 로고
    • Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer
    • Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994;54:1630-3.
    • (1994) Cancer Res , vol.54 , pp. 1630-1633
    • Yamashita, J.1    Ogawa, M.2    Yamashita, S.3    Nomura, K.4    Kuramoto, M.5    Saishoji, T.6
  • 15
    • 0029384375 scopus 로고
    • Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum
    • Hanatani M, Tanaka Y, Kondo S, Ohmori I, Suzuki H. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotechnol Biochem 1995;59:1958-9.
    • (1995) Biosci Biotechnol Biochem , vol.59 , pp. 1958-1959
    • Hanatani, M.1    Tanaka, Y.2    Kondo, S.3    Ohmori, I.4    Suzuki, H.5
  • 16
    • 0025619972 scopus 로고
    • Angiogenic growth factors
    • Risau W. Angiogenic growth factors. Proc Growth Factor Res 1990;2:71-9.
    • (1990) Proc Growth Factor Res , vol.2 , pp. 71-79
    • Risau, W.1
  • 17
    • 0028085449 scopus 로고
    • Molecular mechanism of development and tumor angiogenesis
    • Plate KH, Breier G, Risau W. Molecular mechanism of development and tumor angiogenesis. Brain Pathol 1994;4:207-18.
    • (1994) Brain Pathol , vol.4 , pp. 207-218
    • Plate, K.H.1    Breier, G.2    Risau, W.3
  • 19
    • 0026722243 scopus 로고
    • Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
    • Bussolino F, Di Renzo MF, Ziche M, Boochietto E, Olivero M, Naldini L, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-41.
    • (1992) J Cell Biol , vol.119 , pp. 629-641
    • Bussolino, F.1    Di Renzo, M.F.2    Ziche, M.3    Boochietto, E.4    Olivero, M.5    Naldini, L.6
  • 20
    • 0027077443 scopus 로고
    • Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
    • Naldini L, Tamagnone L, Viga E. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992;11:4825-33.
    • (1992) EMBO J , vol.11 , pp. 4825-4833
    • Naldini, L.1    Tamagnone, L.2    Viga, E.3
  • 21
    • 0027761342 scopus 로고
    • Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA
    • Wendy M, Zarnegar R, Michalopoulos K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993;143:949-58.
    • (1993) Am J Pathol , vol.143 , pp. 949-958
    • Wendy, M.1    Zarnegar, R.2    Michalopoulos, K.3
  • 22
    • 0025753774 scopus 로고
    • MCF-7 mammary carcinoma cells respond to bFGF and internalize it following its release from extracellular matrix: A permissive role of cathepsin D
    • Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D, et al. MCF-7 mammary carcinoma cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 1991;194:252-9.
    • (1991) Exp Cell Res , vol.194 , pp. 252-259
    • Briozzo, P.1    Badet, J.2    Capony, F.3    Pieri, I.4    Montcourrier, P.5    Barritault, D.6
  • 23
    • 0025318680 scopus 로고
    • Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity
    • Saksela O, Rifkin DB. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 1990; 110:767-75.
    • (1990) J Cell Biol , vol.110 , pp. 767-775
    • Saksela, O.1    Rifkin, D.B.2
  • 24
    • 0025204095 scopus 로고
    • Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth
    • Ingber D, Fujita T, Kashimoto S, Sudo K, Kanamaru T, Berm H, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990;348:555-7.
    • (1990) Nature , vol.348 , pp. 555-557
    • Ingber, D.1    Fujita, T.2    Kashimoto, S.3    Sudo, K.4    Kanamaru, T.5    Berm, H.6
  • 25
    • 0028929803 scopus 로고
    • Aniogenesis in cancer, vascular, rheumatoid and other disease
    • Folkman J. Aniogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995;1:27-31.
    • (1995) Nature Med , vol.1 , pp. 27-31
    • Folkman, J.1
  • 26
    • 0028951043 scopus 로고
    • Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
    • Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1995;1: 149-53.
    • (1995) Nature Med , vol.1 , pp. 149-153
    • Holmgren, L.1    O'Reilly, M.S.2    Folkman, J.3
  • 27
    • 0027197245 scopus 로고
    • Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
    • Kim KJ, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993;362:841-4.
    • (1993) Nature , vol.362 , pp. 841-844
    • Kim, K.J.1    Winer, J.2    Armanini, M.3    Gillett, N.4    Phillips, H.S.5    Ferrara, N.6
  • 28
    • 0027272655 scopus 로고
    • Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody
    • Kondo S, Asano M, Suzuki H. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 1993;194:1234-41.
    • (1993) Biochem Biophys Res Commun , vol.194 , pp. 1234-1241
    • Kondo, S.1    Asano, M.2    Suzuki, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.